Nasal Cannula Market, by Type (Curved Prong, Flared Prong, Curved and Flared Prong, Straight Prong), End Use (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Long Term Care Centers, Others), Material (Plastic, Silicone): Global Opportunity Analysis and Industry Forecast, 2024-2033

The nasal cannula market was valued at $7.3 billion in 2023 and is estimated to reach $12.6 billion by 2033, exhibiting a CAGR of 5.7% from 2024 to 2033.

Market Introduction and Overview

A nasal cannula is a vital medical device utilized to administer supplemental oxygen therapy, particularly for individuals with reduced oxygen levels. Comprising two prongs, it delicately rests below the nose, directly delivering oxygen into the nostrils. There are two primary types of nasal cannulas, low flow and high flow. High Flow Nasal Cannulas (HFNC) dispense humidified, heated oxygen, capable of supplying up to 60 liters per minute. In contrast, low flow cannulas offer a more limited range, typically delivering 4-6 liters per minute without heating or humidification. While low flow cannulas are effective, they may dry out nasal passages, potentially leading to irritation or bleeding. Nasal cannulas find application across various medical conditions like respiratory failure, heart failure, sleep apnea, and even during interventions like intubation or extubation.

Key Takeaways

• The nasal cannula market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($billion) for the projected period from 2024 to 2033.
• More than 1,500 product literatures, industry releases, annual reports, and other such documents of major Nasal cannula industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
• The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.

Industry Trends

• In March 2024, a retrospective cohort study led by Robert J. Willer, DO, of the University of Utah School of Medicine, suggested a shift to weight-based high-flow nasal cannula (HFNC) protocols that reduced ICU admissions for children with bronchiolitis. Analyzing data from 18 children's hospitals, the study revealed a 6.1% yearly decrease in ICU admissions and a 1.5% reduction in noninvasive positive pressure ventilation (NIPPV) usage with the new protocol. Despite similar lengths of stay and mechanical ventilation rates, the study emphasizes the potential of weight-based HFNC protocols in alleviating ICU burden for pediatric bronchiolitis patients.
• In January 2024, a study conducted by researchers at the Affiliated Hospital of Xuzhou Medical University in China investigated into predicting high-flow nasal oxygen (HFNO) therapy failure in patients with acute respiratory failure (ARF) using machine learning (ML) algorithms. Analyzing data from 700 ARF patients receiving HFNO, the study developed seven predictive models, showcasing robust performance. The models, evaluated through various metrics, highlighted the potential of ML techniques in accurately forecasting HFNO outcomes. Identified independent risk factors for HFNO failure included the logistic organ dysfunction score (LODS) and oxygenation index. This research highlights the significance of ML in enhancing risk management for ARF patients undergoing HFNO therapy.

Key Market Dynamics

The nasal cannula market is experiencing significant growth driven by several key factors. For instance, the rising prevalence of respiratory diseases such as COPD, asthma, and sleep apnea, is leading to an increase in the demand for oxygen therapy devices like nasal cannulas. Also, advancements in technology, such as the development of high-flow nasal cannulas offering better comfort and efficacy, are driving the market growth.

Despite their benefits, nasal cannulas also come with limitations and restraints. Nasal dryness or irritation is a common issue, which can be alleviated with water-based ointments or saline sprays. However, in high-flow nasal cannulas, this discomfort can be mitigated with a humidifier unit. In addition, the flammability of oxygen poses a risk, requiring careful usage away from open flames or flammable materials. Moreover, prolonged exposure to high levels of oxygen can lead to lung damage or pulmonary oxygen toxicity, necessitating cautious monitoring of oxygen levels during therapy.

The nasal cannula industry presents significant opportunities for growth and innovation with a focus on enhancing comfort, personalization, and precision in oxygen delivery. Opportunities lie in developing even more ergonomic designs, incorporating smart technologies for wireless monitoring and data connectivity, and improving real-time feedback mechanisms. As the demand for respiratory support continues to rise, the nasal cannula industry is poised to meet these needs with innovative solutions that prioritize patient well-being.

Global Nasal Cannula Market Ecosystem Analysis

Nasal cannulas play a crucial role in treating respiratory diseases by delivering supplemental oxygen to patients. This helps improve their breathing, alleviate symptoms, and enhance their overall quality of life. Nasal cannulas are commonly used in managing conditions such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer, providing patients with the necessary oxygen support they need to breathe more comfortably and effectively.

As of 2023, more than 34 million Americans lived with chronic lung diseases like asthma and COPD, with asthma affecting 26.8 million individuals, including 4.5 million children. About 11.7 million adults have been diagnosed with COPD, but the actual number may be higher due to undiagnosed cases.

Respiratory Disease Statistics in the U.S.

Market Segmentation

The nasal cannula market is segmented into type, material, end user, and region. On the basis of type, the market is divided into low flow nasal cannula and high flow nasal cannula. Based on material, the market is divided into plastic and silicone. Based on end user, the market is divided into hospitals, ambulatory healthcare services, long term care centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Country Market Outlook

The statistics on asthma in the U.S. emphasizes the urgent need for effective management and treatment, especially among vulnerable populations. For instance, in 2021, 39.6% of adults aged 18 and older who had asthma reported having one or more asthma attacks in the last year.

On average, 10 people in the U.S. die from asthma each day. In 2021, 3,517 people died from asthma. Nearly all of these deaths are avoidable with the right treatment and care. Also, adults are 6 times more likely to die from asthma than children.

The prevalence of chronic bronchitis (CB) in the U.S., affecting approximately 10 million people every year, highlights the significant burden of respiratory diseases like COPD. As CB often coexists with COPD, which affects over 34.6% of patients with moderate to severe stages of the disease, the demand for effective management strategies is high.

Nasal cannula, a device used to deliver supplemental oxygen, plays a crucial role in managing COPD and its associated symptoms, including chronic bronchitis. With COPD being the third leading cause of death in the world, the need for respiratory support devices like nasal cannula is evident.

Competitive Landscape

The major players operating in the nasal cannula market include Allied Healthcare Products Inc., Teleflex Incorporated, Flexicare Medical Ltd., Vapotherm Inc., ResMed Inc., Fairmont Medical, Fisher & Paykel Healthcare Limited, Well Lead Medical Co. Ltd., Salter Labs, and others.

Recent Key Strategies and Developments

• In March 2024, Onymos and Vapotherm joined forces to create an end-to-end Internet of Medical Things (IoMT) solution, aimed at enhancing respiratory care. Leveraging Onymos' Features-as-a-Service platform, Vapotherm aims to expedite the development of a secure and robust digital platform for its HVT 2.0 system, catering to both acute care settings and future home applications. This partnership enables Vapotherm to access IoT features like Onymos Edge, Access, and DataStore, ensuring seamless connectivity between devices and the cloud. The solution, currently undergoing beta testing, promises to empower medical teams with real-time clinical insights for informed decision-making, ultimately improving patient outcomes.
• In October 2023, Teleflex Incorporated successfully finalized the acquisition of Palette Life Sciences AB, expanding its Interventional Urology portfolio. With this acquisition, Teleflex gains access to Barrigel, a biodegradable rectal spacer designed to reduce rectal radiation during prostate cancer therapy. In addition, Palette's portfolio includes Deflux and Solesta, aimed at treating pediatric vesicoureteral reflux and fecal incontinence. The transaction, valued at $600 million upfront with potential additional payments of up to $50 million, is expected to enhance Teleflex's revenue growth profile in 2024.

Key Sources Referred

1. American Lung Association
2. FIRS
3. World Health Organization
4. Canadian Lung Association
5. National Library of Medicine
6. ELF European Lung Foundation
7. National Health Council
8. National Organization for Rare Disorders, Inc.
9. U.S. Department of Health & Human Services
10. Asthma and Allergy Foundation of America

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the nasal cannula market segments, current trends, estimations, and dynamics of the nasal cannula market analysis from 2023 to 2033 to identify the prevailing nasal cannula market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the nasal cannula market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global nasal cannula market statistics.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global nasal cannula market trends, key players, market segments, application areas, and market growth strategies.

The report offers comprehensive analysis of key players operating in the global market by analyzing their business performance, product portfolio, business segments, revenue, and strategic moves to showcase the competitive scenario in the industry.